These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33399782)

  • 1. [Risk of infections associated with the use of biological medications; a review].
    Gambra MP; Montesinos JJ; Valenzuela MT; Cárcamo ME; Cavada Ch G
    Rev Med Chil; 2020 Aug; 148(8):1155-1170. PubMed ID: 33399782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease.
    Piovani D; Danese S; Peyrin-Biroulet L; Nikolopoulos GK; Bonovas S
    Aliment Pharmacol Ther; 2020 May; 51(9):820-830. PubMed ID: 32170782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.
    Bonovas S; Fiorino G; Allocca M; Lytras T; Nikolopoulos GK; Peyrin-Biroulet L; Danese S
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1385-1397.e10. PubMed ID: 27189910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
    Borren NZ; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials.
    Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ
    BMJ; 2015 Mar; 350():h1269. PubMed ID: 25770113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study.
    Waljee AK; Higgins PDR; Jensen CB; Villumsen M; Cohen-Mekelburg SA; Wallace BI; Berinstein JA; Allin KH; Jess T
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):276-284. PubMed ID: 31836320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network meta-analyses of systemic treatments for psoriasis: a critical appraisal: Original Articles: Jabbar-Lopez ZK, Yiu ZZN, Ward V et al. Quantitative evaluation of biologic therapy options for psoriasis: a systematic review and network meta-analysis. J Invest Dermatol 2017; 137:1646-54. Sbidian E, Chaimani A, Garcia-Doval I et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev 2017; 12:CD011535.
    Ellis AG; Flohr C; Drucker AM
    Br J Dermatol; 2019 Feb; 180(2):282-288. PubMed ID: 30347448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease.
    Hindryckx P; Novak G; Bonovas S; Peyrin-Biroulet L; Danese S
    Clin Pharmacol Ther; 2017 Oct; 102(4):633-641. PubMed ID: 28699217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review.
    Desai RJ; Thaler KJ; Mahlknecht P; Gartlehner G; McDonagh MS; Mesgarpour B; Mazinanian A; Glechner A; Gopalakrishnan C; Hansen RA
    Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1078-88. PubMed ID: 26663412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.
    Adelzadeh L; Jourabchi N; Wu JJ
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):846-52. PubMed ID: 25081573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active pharmacovigilance program in patients affected by psoriasis and inflammatory bowel diseases
.
    Vergani HM; Calvini G; Mangini G; Mattioli F; Parodi A; Burlando M; Bodini G; Martelli A
    Int J Clin Pharmacol Ther; 2020 Apr; 58(4):208-213. PubMed ID: 32053103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of levetiracetam in children with epilepsy: protocol for an umbrella review of systematic reviews and meta-analyses of randomised controlled trials.
    Gan J; Ma D; Xiong T
    BMJ Open; 2019 Jul; 9(7):e029811. PubMed ID: 31296513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions during biological drug therapy in psoriasis:clinical series and a review of the literature.
    Montesu MA; Addis GM; Satta R; Cottoni F
    G Ital Dermatol Venereol; 2011 Aug; 146(4):273-81. PubMed ID: 21785393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic-Induced Infections in Inflammatory Bowel Disease: The TNF-α Antagonists.
    McConachie SM; Wilhelm SM; Bhargava A; Kale-Pradhan PB
    Ann Pharmacother; 2018 Jun; 52(6):571-579. PubMed ID: 29363355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease.
    Gong SS; Fan YH; Han QQ; Lv B; Xu Y
    World J Gastroenterol; 2019 May; 25(18):2240-2250. PubMed ID: 31143074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.
    Lee WJ; Lee TA; Calip GS; Suda KJ; Briars L; Schumock GT
    Inflamm Bowel Dis; 2018 Mar; 24(4):883-891. PubMed ID: 29562275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic reviews and meta-analyses on psoriasis: role of funding sources, conflict of interest and bibliometric indices as predictors of methodological quality.
    Gómez-García F; Ruano J; Aguilar-Luque M; Gay-Mimbrera J; Maestre-Lopez B; Sanz-Cabanillas JL; Carmona-Fernández PJ; González-Padilla M; Vélez García-Nieto A; Isla-Tejera B
    Br J Dermatol; 2017 Jun; 176(6):1633-1644. PubMed ID: 28192600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation.
    Whitlock SM; Enos CW; Armstrong AW; Gottlieb A; Langley RG; Lebwohl M; Merola JF; Ryan C; Siegel MP; Weinberg JM; Wu JJ; Van Voorhees AS
    J Am Acad Dermatol; 2018 Feb; 78(2):383-394. PubMed ID: 29332708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.
    Chen Y; Sun J; Yang Y; Huang Y; Liu G
    Clin Rheumatol; 2016 Jan; 35(1):1-18. PubMed ID: 26573205
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.